DOPAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dopamine, and when can generic versions of Dopamine launch?
Dopamine is a drug marketed by Abbott, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hikma Intl Pharms, Hospira, Igi Labs Inc, Intl Medication, Lyphomed, Smith And Nephew, Teligent, Teva Parenteral, Warner Chilcott, and B Braun. and is included in thirty-six NDAs.
The generic ingredient in DOPAMINE is dopamine hydrochloride. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dopamine
A generic version of DOPAMINE was approved as dopamine hydrochloride by HOSPIRA on February 4th, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DOPAMINE?
- What are the global sales for DOPAMINE?
- What is Average Wholesale Price for DOPAMINE?
Summary for DOPAMINE
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 36 |
| Drug Prices: | Drug price information for DOPAMINE |
| DailyMed Link: | DOPAMINE at DailyMed |


